Curia Global Holdings

Curia is a leading contract research, development, and manufacturing organization (CDMO) that provides comprehensive services from drug discovery through commercial manufacturing. Formerly known as AMRI, the company rebranded to Curia in 2021 to emphasize its role as a holistic partner for pharmaceutical and biotechnology companies. Curia offers specialized expertise in complex small molecules, biologics, and sterile fill-finish operations across a global network of facilities. The company supports a wide range of therapeutic modalities, including highly potent APIs, peptides, and advanced delivery systems like lipid nanoparticles (LNPs). With over three decades of experience, Curia enables its partners to accelerate the transition from R&D to market-ready products.